Home   Business   Life Science

Subscribe Now

Life Science




Healx’s $47m Series C raise will speed up Healnet’s drug discoveries

Healx’s $47m Series C raise will speed up Healnet’s drug discoveries

Healx’s $47m Series C raise will speed up Healnet’s drug discoveries

First Phase 2 clinical trial as FDA approval sought.


Life sciences networking events organiser Conexen to open in Oxford and London

Life sciences networking events organiser Conexen to open in Oxford and London

Life sciences networking events organiser Conexen to open in Oxford and London

Next Cambridge meet-up is 18 September.


Winners of the 2024 Cambridge Independent Science and Technology Awards revealed

Winners of the 2024 Cambridge Independent Science and Technology Awards revealed

Winners of the 2024 Cambridge Independent Science and Technology Awards revealed

Find out who triumphed in the annual awards, held on the Wellcome Genome Campus.


Pangenomics to enter the quantum era with ‘incredibly exciting’ $3.5m project

Pangenomics to enter the quantum era with ‘incredibly exciting’ $3.5m project

Pangenomics to enter the quantum era with ‘incredibly exciting’ $3.5m project

University of Cambridge, Wellcome Sanger Institute and EMBL-EBI to team up.


AstraZeneca completes equity investment in Cellectis

AstraZeneca completes equity investment in Cellectis

AstraZeneca completes equity investment in Cellectis

It now has a 44 per cent stake in the clinical-stage biotechnology company.


How Nanocage vaccine could provide broad protection against coronaviruses - including ones we don’t know exist yet

How Nanocage vaccine could provide broad protection against coronaviruses - including ones we don’t know exist yet

How Nanocage vaccine could provide broad protection against coronaviruses - including ones we don’t know exist yet

Cambridge, Oxford and Caltech researchers have tested it in mice so far.


Results speak of “bright and profitable future” for Cambridge Cognition

Results speak of “bright and profitable future” for Cambridge Cognition

Results speak of “bright and profitable future” for Cambridge Cognition

Neuroscience technologies to assess cognitive function go global.


ELRIG UK enters into partnership with life science recruitment leaders SRG

ELRIG UK enters into partnership with life science recruitment leaders SRG

ELRIG UK enters into partnership with life science recruitment leaders SRG

Helping to grow the sector with access to career opportunities.


Markus Lusser takes charge at Abcam

Markus Lusser takes charge at Abcam

Markus Lusser takes charge at Abcam

New president is seasoned Danaher executive.


Cellular Highways hits the Highway1 launch button

Cellular Highways hits the Highway1 launch button

Cellular Highways hits the Highway1 launch button

World’s fastest chip-based cell sorting tool now available for installation.


Neobe Therapeutics closes $2.3m round for its cancer disruptor

Neobe Therapeutics closes $2.3m round for its cancer disruptor

Neobe Therapeutics closes $2.3m round for its cancer disruptor

Synthetic biology start-up acts on tumours without affecting healthy tissues.


Bidwells to support CEO of the Year at the Cambridge Independent Science and Technology Awards 2024

Bidwells to support CEO of the Year at the Cambridge Independent Science and Technology Awards 2024

Bidwells to support CEO of the Year at the Cambridge Independent Science and Technology Awards 2024

The property consultancy has worked with more than 60 science parks and innovation districts in five years.


DeepMirror launches early access programme for AI drug discovery

DeepMirror launches early access programme for AI drug discovery

DeepMirror launches early access programme for AI drug discovery

Cambridge company spun out of University in 2019.


Nicki Thompson joins Camena Bioscience as chair of the board

Nicki Thompson joins Camena Bioscience as chair of the board

Nicki Thompson joins Camena Bioscience as chair of the board

Former Amphista Therapeutics guiding light now chairs synthetic biology company.


This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies - Learn More